ACO Public Reporting Information

Organizational Information

  • ACO Participants

    ACO Participant in Joint Venture (Y or N)

  • Allergy Asthma Sinus Center

    N

  • Carolina Family Practice PA

    N

  • Florence Ears Nose & Throat, PC

    N

  • Healing Hands Family Practice, PLLC

    N

  • Internal Medicine Specialists of Florence, LLC

    N

  • Lumberton Internal Medicine Group, PA

    N

  • McLeod Health Cheraw

    N

  • McLeod Health Clarendon

    N

  • McLeod Loris Seacoast Hospital

    N

  • McLeod Medical Center-Dillon

    N

  • McLeod Physician Associates II

    N

  • Mcleod Regional Medical Center of The Pee Dee Inc

    N

  • Palmetto Radiation Oncology PA

    N

  • Plastic & Reconstructive Surgery of Sumter, PA

    N

  • W Dean Lorenz, MD PA

    N

ACO Governing Body

  • Member Last Name

    Member First Name

    Member Title/Position

    Member Voting Power

    Membership Type

    ACO Participant Legal Business Name/DBA, if applicable

  • Alexander

    C. Richard

    Chair

    1

    ACO Participant Representative

    McLeod Regional Medical Center

  • Farrell

    Howard

    Voting Member

    1

    ACO Participant Representative

    Florence Ears, Nose, and Throat

  • Jagadeesha

    Vinay

    Voting Member

    1

    ACO Participant Representative

    McLeod Regional Medical Center

  • Johnson

    Matt

    Voting Member

    1

    ACO Participant Representative

    McLeod Health

  • Jones

    Jennifer

    Voting Member

    1

    ACO Participant Representative

    McLeod Physician Associates II

  • Boyd

    William

    Voting Member

    1

    Medicare Beneficiary Respresentative

Key ACO Clinical and Administrative Leadership

  • ACO Executive

    Michelle Dore

  • Medical Director

    Dr. Winston Plunkett

  • Compliance Officer

    Jennifer Kirchner

  • Quality Assurance/Improvement Officer

    Michelle Dore

Associated Committees and Committee Leadership

  • Quality Operations Committee

    Alan Blaker, MD, Chair

  • Payment Transformation & Finance Committee

    William Boulware, MD, Chair

Types of ACO Participants or Combinations of Participants that Formed the ACO

  • ACO professionals in a group practice arrangement
  • Hospital employing ACO professionals
  • Network of individual practices of ACO professionals

Shared Savings and Losses

Amount of Shared Savings/Losses:

  • Second Agreement Period
    • Performance Year 2022, $0
  • First Agreement Period
    • Performance Year 2018, $4,347,851
    • Performance Year 2019, $4,225,332
    • Performance Year 2020, $0
    • Performance Year 2021, $0

Shared Savings Distribution:

  • Second Agreement Period
    • Performance Year 2022
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
  • First Agreement Period
    • Performance Year 2018
      • Proportion invested in infrastructure: 100%
      • Proportion invested in redesigned care processes/resources: 0%
      • Proportion of distribution to ACO participants: 0%
    • Performance Year 2019
      • Proportion invested in infrastructure: 15%
      • Proportion invested in redesigned care processes/resources: 0%
      • Proportion of distribution to ACO participants: 85%
    • Performance Year 2020
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A
    • Performance Year 2021
        • Proportion invested in infrastructure: N/A
        • Proportion invested in redesigned care processes/resources: N/A
        • Proportion of distribution to ACO participants: N/A
2022 Quality Performance Results

  • ACO#

    Measure Name

    Rate

    ACO Mean

  • 43

    All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions

    0.1520

    .1510

  • 13

    Falls: Screening for Future Fall Risk

    84.74

    87.83

  • 14

    Preventive Care and Screening: Influenza Immunization

    99.61

    77.34

  • 17

    Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention

    85.71

    79.27

  • 18

    Preventive Care and Screening: Screening for Depression and Follow-up Plan

    71.60

    76.97

  • 19

    Colorectal Cancer Screening

    86.00

    75.32

  • 20

    Breast Cancer Screening

    76.40

    78.07

  • 42

    Statin Therapy for the Prevention and Treatment of Cardiovascular Disease

    96.51

    86.37

  • 27

    Diabetes: Hemoglobin A 1 c Poor Control (>9%)

    9.68

    10.71

  • 28

    Controlling High Blood Pressure

    70.56

    76.16

  • 370

    Depression Remission at 12 months

    15.38

    16.03

For Previous Years’ Financial and Quality Performance Results, please visit data.cms.gov.

Payment Rule Waivers

  • Skilled Nursing Facility (SNF) 3-Day Rule Waiver:
    • Our ACO uses the SNF 3-Day Rule Waiver, pursuant to 42 CFR § 425.612.
  • Waiver for Payment for Telehealth Services:
    • Our ACO clinicians provide telehealth services using the flexibilities under 42 CFR § 425.612(f) and 42 CFR § 425.613.

Fraud and Abuse Waivers

ACO Participation Waiver:

The following information describes each arrangement for which our ACO seeks protection under the ACO Participation Waiver, including any material amendment or modification to a disclosed arrangement.

  • Parties to the arrangement: ACO Facility Participants, ACO Practice Participants, including Independently owned Physician Practices
  • Date of arrangement: 05/23/2021
  • Items, services, goods, or facility provided: OP-CDI Program Manager; dedicated OP-CDI specialists; technology to support opportunity assessment, workflow development, and monitor program performance
  • Date and nature of any amendments to the arrangement, if applicable: N/A